Intervention not reported
Relapse, progression or death (calculated instead of PFS)
The intervention probably leads to lower relapse, progression or death (calculated instead of PFS) (moderate certainty).
1 finding from 1 review
Intervention not reported
Infection‐ related mortality
The intervention showed no clear difference in infection‐ related mortality (low certainty).
1 finding from 1 review
Intervention not reported
Second cancer‐ related mortality
The intervention showed no clear difference in second cancer‐ related mortality (low certainty).
1 finding from 1 review
Intervention not reported
Cardiac disease‐ related mortality
The intervention showed no clear difference in cardiac disease‐ related mortality (low certainty).
1 finding from 1 review
Intervention not reported
Complete response rate
The intervention showed no clear difference in complete response rate (low certainty).
1 finding from 1 review
Intervention not reported
Mortality (calculated instead of overall survival)
The intervention may leads to higher mortality (calculated instead of overall survival) (low certainty).
1 finding from 1 review
Intervention not reported
Relapse, progression or death (calculated instead of PFS)
The intervention showed no clear difference in relapse, progression or death (calculated instead of PFS) (low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life (HRQOL), SD units: measured on FACIT‐Pal, TOI of FACT‐Hep, TOI of FACT‐L, FACT‐G, McGill Quality of Life, FACIT‐Sp. Higher scores indicate better HRQOL. · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Health‐related quality of life (HRQOL), natural units: measured on FACT‐G (from 0 to 108) · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Survival: estimated with the unadjusted death hazard ratio · patients with advanced cancer
It is very uncertain whether the intervention changes survival: estimated with the unadjusted death hazard ratio (very low certainty).
1 finding from 1 review
Intervention not reported
Depression, SD units: measured on CES‐D, HADS‐D, PHQ‐9. Higher scores indicate higher depressive symptom load. · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Depression, natural units: measured on CES‐D (from 0 to 60). Higher scores indicate higher depressive symptom load · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Symptom intensity, SD units: measured on ESAS, QUAL‐E Symptom Impact Subscale, SDS, RSC, LCS of FACT‐L, HCS of FACT‐Hep. Higher scores indicate higher symptom intensity. · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Symptom intensity, natural units: measured on ESAS (from 0 to 900). · patients with advanced cancer
1 finding from 1 review
Intervention not reported
Adverse events · patients with advanced cancer
1 finding from 1 review
Length of labour (hours) · healthy pregnant women
1 finding from 1 review
Instrumental vaginal birth · healthy pregnant women
Home support showed no clear difference in rate of instrumental vaginal birth compared with telephone triage (low certainty).
1 finding from 1 review
Serious maternal morbidity · healthy pregnant women
Home support showed no clear difference in serious maternal morbidity compared with telephone triage (low certainty).
1 finding from 1 review
Use of epidural or any regional anaesthesia · healthy pregnant women
Home support showed no clear difference in use of epidural or any regional anaesthesia compared with telephone triage (low certainty).
1 finding from 1 review
Neonatal admission to special care · healthy pregnant women
It is very uncertain whether home support changes neonatal admission to special care compared with telephone triage (very low certainty).
1 finding from 1 review